Simplex Trading
ZNTL icon

Simplex Trading’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Simplex Trading’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$231K Buy
+98,554
New +$255K ﹤0.01% 4135
2025
Q3 		– Sell
-9,699
Closed -$14.5K – 10251
2025
Q2 		$11K Buy
9,699
+8,154
+528% +$10.8K ﹤0.01% 7278
2025
Q1 		$2K Buy
+1,545
New +$3.33K ﹤0.01% 8108
2024
Q4 		– Sell
-267
Closed -$875 – 9805
2024
Q3 		$0 Sell
267
-300
-53% -$1.09K ﹤0.01% 9754
2024
Q2 		$2K Buy
+567
New +$6.33K ﹤0.01% 8371
2024
Q1 		– Sell
-31,078
Closed -$427K – 10089
2023
Q4 		$470K Buy
31,078
+28,865
+1,304% +$421K ﹤0.01% 3768
2023
Q3 		$44K Buy
+2,213
New +$56.2K ﹤0.01% 5933

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Simplex Trading's ZNTL Position: Q1 2026 in Review

Simplex Trading opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q1 2026: 98,554 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #4135 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ZNTL as recently as Q2 2025.

Simplex Trading first reported a position in ZNTL in Q3 2023 and has held it in 7 quarters since. The position peaked at $470K in Q4 2023. 102 funds tracked by Wall St. Rank hold ZNTL as of Q1 2026.

  • Simplex Trading held 98,554 shares of Zentalis Pharmaceuticals worth $231K as of Q1 2026.
  • Zentalis Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • Zentalis Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4135 holding.
  • Simplex Trading first reported a position in Zentalis Pharmaceuticals in Q3 2023 and has held it in 7 quarters since.
  • Simplex Trading's Zentalis Pharmaceuticals position peaked at $470K in Q4 2023.
  • 102 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.